Lupus Patient Develops Miller Fisher Variant of Guillain-Barré Syndrome

Sedrick Bradley, MD, & Nirupa J. Patel, MD | Issue: October 2018 | October 18, 2018

Page: 1 2 3 4 5 | Single Page

Genome-Wide Association Studies of SLE

February 12, 2011

What do these studies tell us about disease mechanisms in lupus?

Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease

December 1, 2014

A review of data on antinuclear antibodies and tests for rheumatoid arthritis

U.S. to Announce New Warning on J&J Coronavirus Vaccine for Guillain-Barré Syndrome

July 12, 2021

(Reuters)—The U.S. Food & Drug Administration (FDA) is expected to announce a new warning on Johnson & Johnson’s (J&J’s) coronavirus vaccine related to a rare autoimmune disorder, The Washington Post reported on Monday, citing four people familiar with the matter.1 According to The Post, about 100 preliminary reports of Guillain-Barré syndrome have been detected in the…

Shortcomings and Promises of Genome-wide Association Studies

February 3, 2012

The outcomes of genome-wide association studies (GWAS) have not been what scientists expected, but researchers are developing new approaches to use revelatory GWAS information to identify genetic causal variants, predictors of treatment response, and future opportunities for genetic insight.

Related Articles